Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Artur J, Szkotak"'
Autor:
Steven Dang, Artur J. Szkotak, Joshua E. Raizman, Anna K. Füzéry, Cheryl Babiak, Albert K.Y. Tsui, Richard Herndon
Publikováno v:
Clinical biochemistry. 91
Objectives Hydroxocobalamin (OHCob) is an antidote for cyanide poisoning in patients rescued from house fires and is known to cause interference with certain laboratory tests. Consensus is lacking on the extent of this interference and on how to hand
Autor:
Donna L. Forrest, Thomas J. Nevill, Maryse M. Power, James T. England, Florian Kuchenbauer, David Sanford, Donna E. Hogge, Joseph Brandwein, Lalit Saini, Monika Hudoba, Sujaatha Narayanan, Artur J. Szkotak
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(7)
The 2017 National Comprehensive Cancer Network guidelines for acute myeloid leukemia have recommended performing bone marrow (BM) aspiration and BM trephine biopsy (BMTB) 14 to 21 days after starting induction therapy (commonly referred to as "day 14
Publikováno v:
Clinical chemistry. 66(4)
Publikováno v:
Investigative ophthalmologyvisual science. 59(11)
Purpose To confirm whether choroideremia (CHM) is a systemic disease characterized by blood lipid abnormalities and crystals found in, or associated with, circulating peripheral blood cells of patients. Methods Peripheral blood samples obtained from
Publikováno v:
Canadian Journal of General Internal Medicine. 13
Intravesical administration of Bacillus Calmette-Guerin (BCG) is a cornerstone of adjuvant treatment for low-grade urothelial carcinoma. Complications from administration are relatively rare and generally evident within one month. Systemic BCG infect
Publikováno v:
Leukemialymphoma. 59(1)
We evaluated the impact of bone marrow sample characteristics on the detection of persistent cytogenetic abnormalities (PCA) following induction chemotherapy for acute myeloid leukemia (AML). PCA's were identified in 20.4% of patients and were more c
Publikováno v:
Blood Coagulation & Fibrinolysis. 25:426-434
Complications while on dabigatran therapy, particularly bleeding and thrombosis, are occurring, and require laboratory assessment. The utility of routine coagulation assays has been previously evaluated in stable patients, but not those with acute co
Autor:
Sol Schulman, Daniel J. Hampshire, Jennifer Jolley, Peter A. Smethurst, Willem H. Ouwehand, Alan T. Nurden, Ilenia Simeoni, William Stevenson, Paolo Gresele, Ri Liesner, Kathleen Freson, Christel Van Geet, Walter H. A. Kahr, Tadbir K. Bariana, Paquita Nurden, Minka J A Vries, David A. Wilcox, Mary Mathias, Fengyuan Hu, Maha Othman, Marguerite Neerman-Arbez, Pawan Poudel, Matthias Ballmaier, Pieter H. Reitsma, Peter William Collins, Jose A. Lopez, Artur J. Szkotak, Jose A. Guerrero, Marie-Christine Alessi, Manuela Germeshausen, Jonathan Stephens, Cedric Ghevaert, Michael Gattens, Carolyn M. Millar, Gareth Baynam, Marian Hill, Marco Cattaneo, Antony P. Attwood, Shoshana Revel-Vilk, Matthew T. Rondina, Anne M. Kelly, Sri V V Deevi, Sofia Papadia, Amit C. Nathwani, Paul F. Bray, Daniel B. Bellissimo, Michael Laffan, Deborah L. French, Daniel P. Hart, Shinji Kunishima, Bin Zhang, Rutendo Mapeta, Salih Tuna, Anne Goodeve, Keith Gomez, Nancy Hogg, Ernest Turro, Johan W. M. Heemskerk, Marta Bertoli, Karyn Megy, Ron Kerr, Christopher J. Penkett, David J. Perry, Claire Lentaigne, Deborah Whitehorn, Daniel Greene, Suthesh Sivapalaratnam, Myrto Kostadima, Andrew D Mumford, Bruce Furie, Emilse Bermejo, Rémi Favier, Michele P. Lambert, Louise C. Daugherty, Yvonne M. C. Henskens, Augusto Rendon, Loredana Bury, Kathelijne Peerlinck, Sarah K Westbury
Publikováno v:
Blood
Blood, American Society of Hematology, 2016, 127 (23), pp.2791-803. ⟨10.1182/blood-2015-12-688267⟩
Simeoni, I, Stephens, J C, Hu, F, Deevi, S V V, Megy, K, Bariana, T K, Lentaigne, C, Schulman, S, Sivapalaratnam, S, Vries, M J A, Westbury, S K, Greene, D, Papadia, S, Alessi, M-C, Attwood, A P, Ballmaier, M, Baynam, G, Bermejo, E, Bertoli, M, Bray, P F, Bury, L, Cattaneo, M, Collins, P, Daugherty, L C, Favier, R, French, D L, Furie, B, Gattens, M, Germeshausen, M, Ghevaert, C, Goodeve, A, Guerrero, J, Hampshire, D J, Hart, D P, Heemskerk, J W M, Henskens, Y M C, Hill, M, Hogg, N, Jolley, J D, Kahr, W H, Kelly, A M, Kerr, R, Kostadima, M, Kunishima, S, Lambert, M P, Liesner, R, Lopez, J, Mapeta, R P, Mathias, M, Millar, C M, Nathwani, A, Neerman-Arbez, M, Nurden, A T, Nurden, P, Othman, M, Peerlinck, K, Perry, D J, Poudel, P, Reitsma, P, Rondina, M, Smethurst, P A, Stevenson, W, Szkotak, A, Tuna, S, van Geet, C, Whitehorn, D, Wilcox, D A, Zhang, B, Revel-Vilk, S, Gresele, P, Bellissimo, D, Penkett, C J, Laffan, M A, Mumford, A D, Rendon, A, Gomez, K, Freson, K, Ouwehand, W H & Turro, E 2016, ' A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorderdisorders ', Blood, vol. 127, no. 23, pp. 2791-2803 . https://doi.org/10.1182/blood-2015-12-688267
Blood, 127(23), 2791-2803
Blood, 127(23), 2791-2803. The American Society of Hematology
Blood, American Society of Hematology, 2016, 127 (23), pp.2791-803. ⟨10.1182/blood-2015-12-688267⟩
Simeoni, I, Stephens, J C, Hu, F, Deevi, S V V, Megy, K, Bariana, T K, Lentaigne, C, Schulman, S, Sivapalaratnam, S, Vries, M J A, Westbury, S K, Greene, D, Papadia, S, Alessi, M-C, Attwood, A P, Ballmaier, M, Baynam, G, Bermejo, E, Bertoli, M, Bray, P F, Bury, L, Cattaneo, M, Collins, P, Daugherty, L C, Favier, R, French, D L, Furie, B, Gattens, M, Germeshausen, M, Ghevaert, C, Goodeve, A, Guerrero, J, Hampshire, D J, Hart, D P, Heemskerk, J W M, Henskens, Y M C, Hill, M, Hogg, N, Jolley, J D, Kahr, W H, Kelly, A M, Kerr, R, Kostadima, M, Kunishima, S, Lambert, M P, Liesner, R, Lopez, J, Mapeta, R P, Mathias, M, Millar, C M, Nathwani, A, Neerman-Arbez, M, Nurden, A T, Nurden, P, Othman, M, Peerlinck, K, Perry, D J, Poudel, P, Reitsma, P, Rondina, M, Smethurst, P A, Stevenson, W, Szkotak, A, Tuna, S, van Geet, C, Whitehorn, D, Wilcox, D A, Zhang, B, Revel-Vilk, S, Gresele, P, Bellissimo, D, Penkett, C J, Laffan, M A, Mumford, A D, Rendon, A, Gomez, K, Freson, K, Ouwehand, W H & Turro, E 2016, ' A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorderdisorders ', Blood, vol. 127, no. 23, pp. 2791-2803 . https://doi.org/10.1182/blood-2015-12-688267
Blood, 127(23), 2791-2803
Blood, 127(23), 2791-2803. The American Society of Hematology
Inherited bleeding, thrombotic and platelet disorders (BPDs) are diseases affecting approximately 300 individuals per million births. With the exception of haemophilia and von Willebrand disease patients, a molecular analysis for patients with a BPD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa352cd1eafdc5697d70b553f05b0503
http://hdl.handle.net/11391/1386441
http://hdl.handle.net/11391/1386441
Publikováno v:
Journal of Hematopathology. 4:21-29
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening inflammatory syndrome characterized by reactive proliferation of histiocytes in hematopoietic tissues, with accompanying hemophagocytosis. A number of primary and secondary triggers have
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 29:710-720
The purpose of this study was to characterize basolateral anion channels in Calu-3 and normal human bronchial epithelial cells, and their role in anion secretion. Patch clamp studies identified an outwardly rectifying Cl- channel (ORCC), which could